Skip to main content
. 2017 Jun 7;9(2):21. doi: 10.3390/pharmaceutics9020021

Figure 6.

Figure 6

Cell viability of 4T1 after 48 h of treatment with gemcitabine-loaded CA and surface modified, gemcitabine-loaded CA. Surface-modified CA denotes the particles modified with streptavidin–biotin–PEG and fibronectin. Values were very significant (**) at p value 0.001 to 0.01, and extremely significant (***) at p value 0.0001 to 0.001.